These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 29700323)
1. HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation. Mohammadi H; Papp E; Cahill L; Rennie M; Banko N; Pinnaduwage L; Lee J; Kibschull M; Dunk C; Sled JG; Serghides L Sci Rep; 2018 Apr; 8(1):6552. PubMed ID: 29700323 [TBL] [Abstract][Full Text] [Related]
2. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction. Papp E; Mohammadi H; Loutfy MR; Yudin MH; Murphy KE; Walmsley SL; Shah R; MacGillivray J; Silverman M; Serghides L J Infect Dis; 2015 Jan; 211(1):10-8. PubMed ID: 25030058 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052. Zangeneh SZ; Wilson EA; Ahluwalia S; Donnell DJ; Chen YQ; Grinsztejn B; Melo MG; Godbole SV; Hosseinipour MC; Taha T; Kumwenda J; McCauley M; Cohen MS; Nielsen-Saines K AIDS Care; 2023 Jun; 35(6):824-832. PubMed ID: 36524872 [TBL] [Abstract][Full Text] [Related]
4. Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review. Premkumar A; Dude AM; Haddad LB; Yee LM Pregnancy Hypertens; 2019 Jul; 17():178-190. PubMed ID: 31487638 [TBL] [Abstract][Full Text] [Related]
5. HIV infection and stroke: current perspectives and future directions. Benjamin LA; Bryer A; Emsley HC; Khoo S; Solomon T; Connor MD Lancet Neurol; 2012 Oct; 11(10):878-90. PubMed ID: 22995692 [TBL] [Abstract][Full Text] [Related]
6. Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens. Kala S; Watson B; Zhang JG; Papp E; Guzman Lenis M; Dennehy M; Cameron DW; Harrigan PR; Serghides L Antiviral Res; 2018 Nov; 159():45-54. PubMed ID: 30236532 [TBL] [Abstract][Full Text] [Related]
7. Exploring the impact of HIV infection and antiretroviral therapy on placenta morphology. Yampolsky M; Shlakhter O; Deng D; Kala S; Walmsley SL; Murphy KE; Yudin MH; MacGillivray J; Loutfy M; Dunk C; Serghides L Placenta; 2021 Jan; 104():102-109. PubMed ID: 33310298 [TBL] [Abstract][Full Text] [Related]
8. Placental progesterone and its receptor in HIV-infected pre-eclamptic women. Sewnarain S; Singh S; Naicker T Histochem Cell Biol; 2024 Mar; 161(3):255-267. PubMed ID: 37975897 [TBL] [Abstract][Full Text] [Related]
9. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis. Saint-Lary L; Benevent J; Damase-Michel C; Vayssière C; Leroy V; Sommet A BMC Pregnancy Childbirth; 2023 Jan; 23(1):80. PubMed ID: 36717801 [TBL] [Abstract][Full Text] [Related]
10. Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study. Chi BH; Sebikari D; Brummel SS; DeMarrais P; Chamanga R; Owor M; Dadabhai S; Price JT; Taha T; Stringer J; Fowler MG PLoS One; 2023; 18(1):e0280730. PubMed ID: 36689442 [TBL] [Abstract][Full Text] [Related]
12. Effects of HIV Infection on Pregnancy Outcomes Among Women Attending Antenatal Care in Referral Hospitals of the Amhara Regional State, Ethiopia: A Prospective Cohort Study. Worku WZ; Azale T; Ayele TA; Mekonnen DK Int J Womens Health; 2022; 14():1405-1423. PubMed ID: 36176965 [TBL] [Abstract][Full Text] [Related]
13. Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis. Shinar S; Agrawal S; Ryu M; Walmsley S; Serghides L; Yudin MH; Murphy KE Acta Obstet Gynecol Scand; 2022 Feb; 101(2):168-182. PubMed ID: 34704251 [TBL] [Abstract][Full Text] [Related]
14. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial. Price JT; Vwalika B; Freeman BL; Cole SR; Saha PT; Mbewe FM; Phiri WM; Peterson M; Muyangwa D; Sindano N; Mwape H; Smithmyer ME; Kasaro MP; Rouse DJ; Goldenberg RL; Chomba E; Stringer JSA Lancet HIV; 2021 Oct; 8(10):e605-e613. PubMed ID: 34509197 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the impact of HIV infection and anti-retroviral treatment on the cardiometabolic health of pregnant mothers and their offspring (ARTMOMSBABES). Nkeh-Chungag BN; Engwa GA; Businge C; Mdondolo M; Pajaro Medina M; Goswami N BMC Cardiovasc Disord; 2021 Jun; 21(1):322. PubMed ID: 34193034 [TBL] [Abstract][Full Text] [Related]
16. Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus. Auriti C; De Rose DU; Santisi A; Martini L; Piersigilli F; Bersani I; Ronchetti MP; Caforio L Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166198. PubMed ID: 34118406 [TBL] [Abstract][Full Text] [Related]
17. The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy. Phoswa WN Front Cardiovasc Med; 2021; 8():613930. PubMed ID: 34055923 [No Abstract] [Full Text] [Related]